BioRender Unveils the World’s First AI Agent that Builds Images for Scientific Research
As inaccurate images from general-purpose AI begin to undermine trust in science, Leo by BioRender offers researchers a fast, accurate, and editable alternative
Nature Medicine Study Shows Resero Bio’s Cell-Free RNA Platform Detects Bladder Cancer and Predicts Treatment Response
A Stanford-led study published in Nature Medicine shows Resero Bio’s uRARE-seq platform detects bladder cancer non-invasively from urine and predicts response to BCG immunotherapy vs. chemotherapy — moving cell-free RNA diagnostics beyond detection into tumor biology.
Inspirata AI Delivers Record Q2 with Five Major Academic Cancer Centers Selecting Its Native AI Platform
/PRNewswire/ — Inspirata AI today announced a record-breaking second quarter, highlighted by five leading academic cancer centers selecting Inspirata AI &…
n6 expands global distribution footprint, bringing iconPCR™ and AutoNorm to more scientists across Europe, the Middle East, and Africa
/PRNewswire/ — n6, maker of the icon96™ and icon16 thermocyclers powered by iconPCR™ with AutoNorm intelligent normalization technology for next‑generation…
New Product Launch: NGS Unique-Dual Indexed Stubby Adapter Kits
For years, Oligo Factory has supplied critical oligonucleotides to NGS platform and genomics tools providers as a trusted OEM manufacturing partner.
Inspirata AI Unveils Rebrand Backed by Two Decades of Cancer Registry Innovation and a Deepened Partnership with ONCO Inc.
TAMPA, Fla., July 16, 2026 /PRNewswire/ — Inspirata today announced it has rebranded as Inspirata AI, marking a new chapter powered by enhanced, native AI-driven cancer casefinding, data abstraction, and reporting capabilities and a strengthened partnership with ONCO Inc.
Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia
CHICAGO, June 11, 2026 (GLOBE NEWSWIRE) — Quetzal Therapeutics, a biopharmaceutical company focused on developing therapies for rare hematologic…
Advaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
Advaita Bio was awarded $1.7M from the National Institute of Health (NIH) to develop a new platform for the analysis of single-cell data.
Singular Genomics Names John Stark as Chief Executive Officer as Company Builds on Spatial Platform Momentum
/PRNewswire/ — Singular Genomics Systems, Inc. today announced the appointment of John Stark as Chief Executive Officer. This leadership transition comes as…
Nomic and Broad Clinical Labs Partner to Integrate Omni 1000 into Discovery and Translational Workflows
Nomic Bio today announced a partnership with Broad Clinical Labs (BCL) to integrate the Nomic platform into its multi-omic workflows.